Filing Details
- Accession Number:
- 0001317757-12-000007
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2012-01-10 16:43:27
- Reporting Period:
- 2012-01-09
- Filing Date:
- 2012-01-10
- Accepted Time:
- 2012-01-10 16:43:27
- Original Submission Date:
- 2012-01-10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 792977 | Amag Pharmaceuticals Inc. | AMAG | Pharmaceutical Preparations (2834) | 042742593 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1317757 | L Joseph Farmer | C/O Amag Pharmaceuticals, Inc. 100 Hayden Avenue Lexington MA 02421 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-01-09 | 8,000 | $0.00 | 8,000 | No | 4 | C | Direct | |
| Common Stock | Disposition | 2012-01-09 | 8,000 | $17.09 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2012-01-09 | 8,000 | $0.00 | 8,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,000 | No | 4 | C | Direct |
Footnotes
- The shares were acquired by the reporting person as a result of the partial vesting of a restricted stock unit grant described below.
- Not applicable.
- The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold on this day. The actual sales prices range from $16.40-$17.955. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- Each restricted stock unit represents a contingent right to receive one share of common stock.
- Grant of restricted stock unit pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. This grant vests as follows: 50% on January 7, 2012, 25% on January 7, 2013 and the remaining 25% on January 7, 2014.
Billionaire Hedge Funds
